FrancophonIA/ELRC3.0 huggingface dataset:
English: SAVOR was a CV outcome trial in 16,492 patients with HbA1c ≥ 6.5 % and < 12 % (12,959 with established CV disease; 3533 with multiple risk factors only) who were randomised to saxagliptin (n=8280) or placebo (n=8212) added to regional standards of care for HbA1c and CV risk factors.
Danish: Saxagliptin vurdering af vaskulære resultater registreret hos patienter med diabetes mellitus trombolyse ved myokardieinfarkt (SAVOR)-studiet SAVOR var et studie af kardiovaskulære resultater hos 16.492 patienter med HbA1c ≥ 6,5 % og < 12 % (12.959 med diagnosticeret kardiovaskulær sygdom; 3.533 kun med multiple risikofaktorer), som blev randomiseret til saxagliptin (n=8.280) eller placebo (n=8.212) som tillæg til regional standardbehandling af HbA1c og kardiovaskulære risikofaktorer.
English: In subjects ≥ 65 years of age, a higher proportion of subjects treated with dapagliflozin had adverse reactions related to volume depletion and renal impairment or failure compared with placebo (see section 4.8).
Danish: En større andel af forsøgspersoner ≥ 65 år, der blev behandlet med dapagliflozin, havde bivirkninger relateret til volumendepletering og nedsat nyrefunktion eller nyresvigt ved sammenligning med placebo (se pkt.
English: Abdominal pain C,
Danish: Dermatitis C,
English: No episodes of major hypoglycaemia were reported, and no subject discontinued the study treatment due to hypoglycaemia (see sections 4.4 and
Danish: Der blev ikke rapporteret alvorlige tilfælde af hypoglykæmi, og ingen forsøgspersoner afbrød studiebehandlingen på grund af hypoglykæmi (se pkt.
English: In a juvenile study, when dapagliflozin was dosed directly to young rats from postnatal day 21 until postnatal day 90, renal pelvic and tubular dilatations (with dose-related increases in kidney weight and macroscopic kidney enlargement) were reported at all dose levels; pup exposures at the lowest dose tested were ≥ 15 times the maximum recommended human dose.
Danish: I et studie med unge dyr, hvor dapagliflozin blev doseret direkte til unge rotter fra dag 21 postnatalt til dag 90, blev der rapporteret dilatation af nyrebækken og -tubuli (med en dosisrelateret stigning i nyrevægt og makroskopisk forstørrede nyrer) ved alle dosisniveauer.
English: Change from baseline (adjusted mean (95 % CI)
Danish: Ændring fra baseline (justeret gennemsnit (95 % CI)
English: Qtern contains lactose
Danish: Qtern indeholder lactose
English: Qtern is used for a type of diabetes called “type 2 diabetes mellitus” in adult patients (aged 18 years and older).
Danish: Qtern anvendes til voksne patienter (i alderen 18 år og ældre) til en type diabetes, der kaldes type 2-diabetes mellitus.
English: Other side effects when taking Qtern alone or in combination with metformin: Common - genital infection (thrush) of your penis or vagina (signs may include irritation, itching, unusual discharge or odour) - back pain - passing more water (urine) than usual or needing to pass water more often - changes in the amount of cholesterol or fats in your blood (shown in tests) - increases in the amount of red blood cells in your blood (shown in tests) - decreases in creatinine renal clearance (shown in tests)
Danish: Andre bivirkninger, når du tager Qtern alene eller i kombination med metformin: Almindelig - infektion (trøske) på penis eller i skeden (tegn på dette kan være irritation, kløe, usædvanlig udflåd eller lugt) - rygsmerter - vandladning af større mængder urin end sædvanligt og hyppigere vandladning - ændringer i mængden af kolesterol eller fedtstoffer i blodet (ses i blodprøver)
English: Skin lesions were not observed at an increased incidence in saxagliptin clinical trials.
Danish: Der er ikke observeret en øget hyppighed af hudlæsioner i kliniske studier med saxagliptin.
English: Qtern should not be used in patients with moderate to severe renal impairment (patients with CrCl < 60 ml/min or eGFR < 60 ml/min/1.73 m2).
Danish: Qtern bør ikke anvendes til patienter med moderat til svært nedsat nyrefunktion (CrCl < 60 ml/min eller eGFR < 60 ml/min/1,73 m2).
English: These are the signs of low blood sugar: - shaking, sweating, feeling very anxious, fast heart beat - feeling hungry, headache, change in vision - a change in your mood or feeling confused.
Danish: Følgende er tegn på lavt blodsukker: - rysten, svedtendens, stærk angstfølelse, hurtig hjerterytme (puls) - sultfornemmelse, hovedpine, synsforstyrrelser - humørsvingninger eller forvirring.
English: Dapagliflozin: In interaction studies conducted in healthy subjects, using mainly a single-dose design, dapagliflozin did not alter the pharmacokinetics of metformin, pioglitazone [a CYP2C8 (major) and CYP3A4 (minor) substrate], sitagliptin, glimepiride (a CYP2C9 substrate), hydrochlorothiazide, bumetanide, valsartan, digoxin (a P-gp substrate) or warfarin (S-warfarin, a CYP2C9 substrate), or the anticoagulatory effects of warfarin as measured by INR.
Danish: Dapagliflozin: I interaktionsstudier udført med raske forsøgspersoner, hvor der hovedsageligt blev anvendt et enkeltdosisdesign, ændrede dapagliflozin ikke i væsentlig grad farmakokinetikken af metformin, pioglitazon [CYP2C8- (major) og CYP3A4- (minor) substrat], sitagliptin, glimepirid (CYP2C9-substrat), hydrochlorthiazid, bumetanid, valsartan, digoxin (P-gp-substrat) eller warfarin (S-warfarin, CYP2C9-substrat) eller den antikoagulerende virkning af warfarin målt ved INR.
English: Shellac
Danish: Prægeblæk Shellac
English: At high doses in rats, saxagliptin caused reduced ossification (a developmental delay) of the foetal pelvis and decreased foetal body weight (in the presence of maternal toxicity), with a NOEL 303 and 30 times the human exposure for saxagliptin and the major metabolite, respectively, at RHD.
Danish: Hos rotter bevirkede høje doser saxagliptin en nedsat ossifikation (en udviklingsforsinkelse) af det føtale pelvis og nedsat føtalvægt (ved maternel toksicitet) med NOEL 303 og 30 gange den humane eksponering af henholdsvis saxagliptin og hovedmetabolitten ved RHD.
English: Dapagliflozin + Metformin Adjusted mean change from baseline
Danish: Dapagliflozin + metformin Justeret gennemsnitlig ændring fra baseline
English: Dapagliflozin: Dapagliflozin did not meaningfully alter the pharmacokinetics of saxagliptin, metformin, pioglitazone, sitagliptin, glimepiride, voglibose, hydrochlorothiazide, bumetanide, valsartan, or simvastatin.
Danish: Dapagliflozin: Dapagliflozin ændrede ikke farmakokinetikken af saxagliptin, metformin, pioglitazon, sitagliptin, glimepirid, voglibose, hydrochlorthiazid, bumetanid, valsartan eller simvastatin væsentligt.
English: Effects on fertility were observed using saxagliptin in male and female rats at high doses producing overt signs of toxicity (see section 5.3).
Danish: Der blev observeret påvirkninger af fertiliteten hos han- og hunrotter ved høje saxagliptindoser, som frembragte åbenlyse tegn på toksicitet (se pkt.
English: Qtern should be discontinued if a serious hypersensitivity reaction is suspected.
Danish: Ved mistanke om en alvorlig overfølsomhedsreaktion skal Qtern seponeres.
English: Qtern can be used in patients with mild renal impairment.
Danish: Qtern kan anvendes til patienter med let nedsat nyrefunktion.
English: Forty-one point four percent (41.4 %) (95 % CI [34.5, 48.2]) of patients in the saxagliptin and dapagliflozin combination group achieved HbA1c levels of less than 7 % compared to 18.3 % (95 % CI [13.0, 23.5]) patients in the saxagliptin group and 22.2 % (95 % CI [16.1, 28.3]) patients in the dapagliflozin group.
Danish: 41,4 % (95 % CI: 34,5-48,2) af patienterne i saxagliptin og dapagliflozin-gruppen opnåede HbA1c-niveauer under 7 % sammenlignet med 18,3 % (95 % CI: 13,0-23,5) i saxagliptingruppen og 22,2 % (95 % CI: 16,1-28,3) i dapagliflozingruppen.
English: Qtern can be used in patients with mild or moderate hepatic impairment.
Danish: Qtern kan anvendes til patienter med let eller moderat nedsat leverfunktion.
English: One trial with saxagliptin and dapagliflozin added concomitantly to metformin was conducted for 24 weeks.
Danish: Det ene studie med saxagliptin og dapagliflozin som tillægsbehandling til metformin varede i 24 uger.
English: The recommended dose is one 5 mg saxagliptin/10 mg dapagliflozin tablet once daily (see sections 4.5 and 4.8).
Danish: Den anbefalede dosis er én tablet med 5 mg saxagliptin/10 mg dapagliflozin én gang dagligt (se pkt.
English: In the concomitant study, the adjusted mean change from baseline in body weight at Week 24 (excluding data after rescue) was −2.05 kg (95 % CI [−2.52, −1.58]) in the saxagliptin 5 mg plus dapagliflozin 10 mg plus metformin group and −2.39 kg (95 % CI [−2.87, −1.91]) in the dapagliflozin 10 mg plus metformin group, while the saxagliptin 5 mg plus metformin group had no change (0.00 kg) (95 % CI [−0.48, 0.49]).
Danish: I det samtidige studie var den justerede gennemsnitlige ændring i legemsvægt fra baseline til uge 24 (eksklusive data efter rescue-medicin) -2,05 kg (95 % CI: [−2,52; −1,58]) i saxagliptin 5 mg plus dapagliflozin 10 mg plus metformin-gruppen og -2,39 kg (95 % CI: [−2,87; −1,91]) i dapagliflozin
English: Dapagliflozin and saxagliptin exposure is increased in patients with severe hepatic impairment (see sections 4.2 and 5.2).
Danish: Eksponeringen for dapagliflozin og saxagliptin øges hos patienter med svært nedsat leverfunktion (se pkt.
English: This medicinal product should not be used in patients with moderate to severe renal impairment (patients with creatinine clearance [CrCl] < 60 ml/min or estimated glomerular filtration rate [eGFR] < 60 ml/min/1.73 m2, see sections 4.4, 4.8, 5.1 and 5.2).
Danish: Dette lægemiddel bør ikke anvendes til patienter med moderat til svært nedsat nyrefunktion (patienter med kreatininclearance [CrCl] < 60 ml/min eller estimeret glomerulær filtrationshastighed [eGFR] < 60 ml/min/1,73 m2, se pkt.
English: Three hundred twenty (320) subjects were randomised equally into either the dapagliflozin added to saxagliptin plus metformin treatment group or placebo plus saxagliptin plus metformin treatment group.
Danish: 320 forsøgspersoner blev ligeligt randomiseret til enten gruppen med dapagliflozin som tillæg til saxagliptin plus metformin eller gruppen med placebo som tillæg til saxagliptin plus metformin.
English: It should also not be used in patients with end-stage renal disease (ESRD) (see section 4.4, 4.8, and 5.2).
Danish: Det bør heller ikke anvendes til patienter med nyresygdom i slutstadie (ESRD) (se pkt.
English: Qtern 5 mg/10 mg film-coated tablets saxagliptin/dapagliflozin
Danish: Qtern 5 mg/10 mg filmovertrukne tabletter saxagliptin/dapagliflozin
English: The formation of dapagliflozin 3-O-glucuronide is mediated by UGT1A9, an enzyme present in the liver and kidney, and CYP-mediated metabolism was a minor clearance pathway in humans.
Danish: Dannelse af dapagliflozin 3-O-glukuronid medieres af UGT1A9, et enzym, der findes i lever og nyrer.
English: Adverse events of genital infection were reported in 3.0 % in the saxagliptin plus dapagliflozin plus metformin group, 0.9 % of saxagliptin plus metformin group and 5.9 % of subjects in the dapagliflozin plus metformin group.
Danish: Bivirkninger i form af genital infektion blev rapporteret hos 3,0 % i saxagliptin plus dapagliflozin plus metformin-gruppen, hos 0,9 % i saxagliptin plus metformin-gruppen og hos 5,9 %
English: In the pooled safety data, urinary tract infections were frequently reported across the 3 treatment groups: 5.7 % in the saxagliptin plus dapagliflozin plus metformin group 7.4 % in the saxagliptin plus metformin group and 5.6 % in the dapagliflozin plus metformin group at 52 weeks (see section 4.8).
Danish: I de puljede sikkerhedsdata blev der hyppigt rapporteret om urinvejsinfektioner i alle 3 behandlingsgrupper: 5,7 % i saxagliptin plus dapagliflozin plus metformin-gruppen, 7,4 % i saxagliptin plus metformin-gruppen og 5,6 % i dapagliflozin plus metformin-gruppen efter 52 uger (se pkt.
English: Hypersensitivity to the active substances or to any of the excipients listed in section 6.1, or history of a serious hypersensitivity reaction, including anaphylactic reaction, anaphylactic shock, and angioedema, to any dipeptidyl peptidase-4 (DPP-4) inhibitor or to any sodium-glucose co-transporter 2 (SGLT2) inhibitor (see sections 4.4, 4.8 and 6.1).
Danish: 6.1 eller tidligere alvorlig overfølsomhedsreaktion, herunder anafylaktisk reaktion, anafylaktisk shock eller angioødem, over for en dipeptidylpeptidase-4 (DPP-4)-hæmmer eller over for en natrium-glucose co-transporter 2 (SGLT2)-hæmmer (se pkt.
English: A total of 534 adult patients with type 2 diabetes mellitus and inadequate glycaemic control on metformin alone (HbA1c ≥ 8 % and ≤ 12 %), participated in this 24-week randomised, double-blind, active comparator-controlled superiority trial to compare the combination of saxagliptin and dapagliflozin added concurrently to metformin, versus saxagliptin (DPP-4 inhibitor) or dapagliflozin (SGLT2 inhibitor) added to metformin.
Danish: I alt 534 voksne patienter med type 2-diabetes mellitus og utilstrækkelig glykæmisk kontrol på monoterapi med metformin (HbA1c ≥ 8 % og ≤ 12 %) deltog i dette randomiserede superioritetsstudie med aktiv kontrol af 24 ugers varighed, som sammenlignede kombinationen med saxagliptin og dapagliflozin som tillægsbehandling til metformin versus saxagliptin (DPP-4-hæmmer) eller dapagliflozin (SGLT2-hæmmer) som tillægsbehandling til metformin.
English: Constipation, dry mouth, pancreatitis
Danish: Obstipation, mundtørhed, pankreatitis
English: Uncommon - thirst - constipation - awakening from sleep at night to pass urine - dry mouth - weight decreased - increases in creatinine or urea (shown in laboratory blood tests) - decrease in kidney function - skin rash that may include raised bumps, skin irritation, or unpleasant itchiness - difficulties in getting or maintaining an erection (erectile dysfunction).
Danish: Ikke almindelig - tørst - forstoppelse - natlig opvågning for at lade vandet - tør mund - vægttab - forhøjet kreatinin eller urea (viser sig i laboratorieblodprøver) - nedsat nyrefunktion - udslæt på huden, der kan omfatte hævede områder, irriteret hud eller ubehagelig kløe - vanskeligheder med at få eller opretholde erektion (impotens) - svampeinfektion - allergiske reaktioner - kløe ved kønsorganerne (genital kløe eller vulvovaginal kløe) eller ubehag, når du lader vandet.
English: If you take more Qtern than you should
Danish: Hvis du har taget for meget Qtern
English: Lower limb amputations
Danish: Amputation af underekstremitet
English: Dapagliflozin 10 mg add to saxagliptin 5 mg + metformin
Danish: Dapagliflozin 10 mg som tillæg til saxagliptin 5 mg + metformin
English: Pack sizes of 14, 28, and 98 film-coated tablets in calendar blisters Pack size of 30 film-coated tablets in blisters
Danish: Pakningsstørrelse på 14, 28 og 98 filmovertrukne tabletter i kalenderblister.
English: Adjusted mean change from baseline
Danish: Justeret gennemsnitlig ændring fra baseline
English: Upper respiratory tract infection
Danish: Øvre luftvejsinfektion
English: Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency, or glucose-galactose malabsorption should not take this medicinal product.
Danish: Tabletterne indeholder lactose og bør ikke anvendes til patienter med arvelig galactoseintolerans, en særlig form af arvelig lactasemangel (Lapp Lactase deficiency) eller glucose/galactosemalabsorption.
English: Decrease in lymphocyte counts
Danish: Nedsat antal lymfocytter
English: Arthralgia, back pain, myalgia
Danish: Artralgi, rygsmerter, myalgi
English: Dapagliflozin: In in vitro studies, dapagliflozin neither inhibited cytochrome P450 (CYP) 1A2, CYP2A6, CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP2D6, CYP3A4, nor induced CYP1A2, CYP2B6 or CYP3A4.
Danish: Dapagliflozin: Dapagliflozin hverken hæmmede CYP1A2, CYP2A6, CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP2D6, CYP3A4 eller inducerede CYP1A2, CYP2B6 eller CYP3A4 i in vitro-studier.
English: Saxagliptin/dapagliflozin combination: The incidence of hypoglycaemia was low (1.4 %) in the saxagliptin plus dapagliflozin plus metformin group, 0.3 % in the saxagliptin plus metformin group, and 1.8 % in the dapagliflozin plus metformin group.
Danish: Saxagliptin/dapagliflozin-kombination: Forekomsten af hypoglykæmi var lav (1,4 %) i saxagliptin plus dapagliflozin plus metformin-gruppen, 0,3 % i saxagliptin plus metformin-gruppen og 1,8 % i dapagliflozin plus metformin-gruppen.
English: The proportion of patients achieving HbA1c < 7.0 % at Week 24 in the add-on therapy with dapagliflozin to saxagliptin plus metformin trial was higher in the dapagliflozin plus saxagliptin plus metformin group 38.0 % (95 % CI [30.9, 45.1]) compared to the placebo plus saxagliptin plus metformin group 12.4 % (95 % CI [7.0, 17.9]).
Danish: Andelen af patienter, der opnåede HbA1c < 7,0 % i uge 24 i studiet med behandling med dapagliflozin som tillæg til saxagliptin plus metformin, var højere i dapagliflozin plus saxagliptin plus metformin-gruppen 38,0 % (95 % CI: 30,9-45,1), sammenlignet med placebo plus saxagliptin plus metformin-gruppen 12,4 % (95 % CI: 7,0-17,9).
English: The group with saxagliptin sequentially added to dapagliflozin and metformin achieved statistically significant (p-value < 0.0001) greater reductions in HbA1c versus the group with placebo sequentially added to dapagliflozin plus metformin group at 24 weeks (see table 4).
Danish: Gruppen med saxagliptin som tillæg til dapagliflozin og metformin opnåede statistisk signifikant (p < 0,0001) større reduktion i HbA1c versus gruppen med placebo som tillæg til dapagliflozin plus metformin ved uge 24 (se tabel 4).
English: The removal of dapagliflozin by haemodialysis has not been studied.
Danish: Fjernelse af dapagliflozin ved hæmodialyse er ikke undersøgt.
English: The group with dapagliflozin sequentially added to saxagliptin and metformin achieved statistically significant (p-value < 0.0001) greater reductions in HbA1c versus the group with placebo sequentially added to saxagliptin plus metformin group at 24 weeks (see table 4).
Danish: Gruppen med dapagliflozin som tillæg til saxagliptin og metformin opnåede statistisk signifikant (p < 0,0001) større reduktion i HbA1c ved uge 24 versus gruppen med placebo som tillæg til saxagliptin plus metformin (se tabel 4).
English: Summary of the safety profile of saxagliptin plus dapagliflozin The combination of saxagliptin 5 mg and dapagliflozin 10 mg in 1169 adults with type 2 diabetes mellitus (T2DM) and inadequate glycaemic control on metformin has been evaluated in three Phase 3, randomised, double-blind, active/placebo-control, parallel group, multi-centre clinical trials for up to 52 weeks (see section 5.1).
Danish: Sammenfatning af sikkerhedsprofilen af saxagliptin plus dapagliflozin Kombinationen af saxagliptin 5 mg og dapagliflozin 10 mg er blevet vurderet i tre randomiserede, dobbeltblinde, aktiv/placebokontrollerede kliniske fase 3-multicenterstudier med parallelle grupper hos 1.169 voksne med type 2-diabetes mellitus (T2DM) og utilstrækkelig glykæmisk kontrol med metformin i op til 52 uger (se pkt.
English: Indigo carmine aluminium lake (E132)
Danish: Indigotin (E132)
English: Saxagliptin 5 mg added to dapagliflozin 10 mg + metformin
Danish: Saxagliptin 5 mg som tillæg til dapagliflozin 10 mg + metformin
English: Saxagliptin/dapagliflozin combination: Events related to volume depletion (hypotension, dehydration, and hypovolemia) were reflective of the adverse events with dapagliflozin and were reported in two subjects (0.4 %) in the saxagliptin plus dapagliflozin plus metformin group (serious adverse event [SAE] of syncope and an AE of urine output decreased), and 3 subjects (0.9 %) in the dapagliflozin plus metformin group (2 AEs of syncope and 1 of hypotension).
Danish: Saxagliptin/dapagliflozin-kombination: Hændelser relateret til volumendepletering (hypotension, dehydrering og hypovolæmi) afspejlede bivirkninger ved dapagliflozin og blev rapporteret hos 2 forsøgspersoner (0,4 %) i saxagliptin plus dapagliflozin-gruppen (en alvorlig bivirkning i form af synkope og en bivirkning i form af nedsat urinproduktion), og hos 3 forsøgspersoner (0,9 %) i dapagliflozin plus metformin-gruppen (2 bivirkninger i form af synkope og 1 i form af hypotension).
English: The same recommendations for monitoring of renal function apply to elderly patients as to all patients (see sections 4.2, 4.4, 4.8, and 5.1).
Danish: De samme anbefalinger for monitorering af nyrefunktionen hos ældre patienter gør sig også gældende for alle andre patienter (se pkt.
English: The proportion of patients achieving HbA1c < 7 % at week 24 for add-on therapy with saxagliptin to dapagliflozin plus metformin trial was higher in the saxagliptin plus dapagliflozin plus metformin group 35.3 % (95 % CI [28.2, 42.2]) compared to the placebo plus dapagliflozin plus metformin group 23.1 % (95 % CI [16.9, 29.3]).
Danish: Andelen af patienter, der opnåede HbA1c < 7 % i uge 24 i studiet med tillægsbehandling med saxagliptin til dapagliflozin plus metformin, var højere i saxagliptin plus dapagliflozin plus metformin-gruppen 35,3 % (95 % CI: 28,2-42,2), sammenlignet med placebo plus dapagliflozin plus metformin-gruppen 23,1 % (95 % CI: 16,9-29,3).
English: AstraZeneca AB SE-151 85 Södertälje Sweden
Danish: AstraZeneca AB SE-151 85 Södertälje Sverige
English: Microcrystalline cellulose (E460i) Croscarmellose sodium (E468) Lactose, anhydrous Magnesium stearate (E470b) Dental type silica (E551)
Danish: Mikrokrystallinsk cellulose (E460i) Croscarmellosenatrium (E468) Lactose, vandfri
English: Fungal infection
Danish: Svampeinfektion
English: Tell your doctor before you start taking Qtern if you have any of these signs.
Danish: Fortæl det til lægen, før du begynder at tage Qtern, hvis du har nogen af disse symptomer.
English: Manufacturer AstraZeneca AB Gärtunavägen SE-151 85 Södertälje Sweden
Danish: Fremstiller AstraZeneca AB Gärtunavägen SE-151 85 Södertälje Sverige
English: AstraZeneca AB Gärtunavägen SE-151 85 Södertälje Sweden
Danish: AstraZeneca AB Gärtunavägen SE-151 85 Södertälje Sverige
English: Saxagliptin: In in vitro studies, saxagliptin and its major metabolite neither inhibited CYP1A2, 2A6, 2B6, 2C8, 2C9, 2C19, 2D6, 2E1, or 3A4, nor induced CYP1A2, 2B6, 2C9, or 3A4.
Danish: Saxagliptin: Saxagliptin eller dets hovedmetabolit hverken hæmmede CYP1A2, CYP2A6, CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP2D6, CYP2E1 eller CYP3A4 eller inducerede CYP1A2, CYP2B6, CYP2C9 eller CYP3A4 i in vitro-studier.
English: Saxagliptin/dapagliflozin combination: In the pooled safety analysis, urinary tract infections (UTIs) were balanced across the 3 treatment groups: 5.7 % in the saxagliptin plus dapagliflozin plus metformin group, 7.4 % in the saxagliptin plus metformin group and 5.6 % in the dapagliflozin plus metformin group.
Danish: Saxagliptin/dapagliflozin-kombination: I den puljede sikkerhedsanalyse var der omtrent lige mange tilfælde af urinvejsinfektioner (UTI) i de 3 behandlingsgrupper: 5,7 % i saxagliptin plus dapagliflozin plus metformin-gruppen, 7,4 % i saxagliptin plus metformin-gruppen og 5,6 % i dapagliflozin plus metformin-gruppen.
English: - Pancreatitis, seen uncommonly (may affect up to 1 in 100 people): severe and persistent pain in the abdomen (stomach area) which might reach through to your back, as well as nausea and vomiting, as it could be a sign of an inflamed pancreas.
Danish: 100 patienter): svære og vedvarende mavesmerter, som kan stråle ud til ryggen, samt kvalme og opkastning.
English: Titanium dioxide (E171) Talc (E553b)
Danish: Titandioxid (E171) Talcum (E553b) Gul jernoxid (E172) Rød jernoxid (E172)
English: Saxagliptin: The metabolism of saxagliptin is primarily mediated by cytochrome P450 3A4/5 (CYP3A4/5).
Danish: Farmakokinetiske interaktioner Saxagliptin: Saxagliptins metabolisme medieres primært af CYP3A4/5.